The Saudi Arabian in-vitro diagnostics (IVD) market is estimated at USD XX billion in 2016 and is projected to reach USD XX billion by the end of 2021, at CAGR of XX % during the forecast period from 2016 to 2021.
An IVD test provides important information about diseases without interacting directly with the human body. IVD plays a major role in the early diagnosis and management of diseases.
IVD has applications in the diagnosis of infectious diseases, diabetes, oncology, cardiology, autoimmune diseases, nephrology, drug testing, HIV/AIDS and others. It is used by clinicians or physicians in hospitals, laboratories, other healthcare settings and at various stages of the patient care pathway.
Saudi Arabia In-Vitro Diagnostics Market-Market Dynamics
Saudi Arabia’s in-vitro diagnostics market is driven by a high demand for technologically advanced equipment for the early and precise diagnosis of diseases, the rise in population, and a rapid increase in the incidence of chronic and infectious diseases. However, the lack of proper reimbursement policies and the stringent regulatory framework are hindering the growth of the market.
The Saudi Arabian in-vitro diagnostics market can be segmented on the basis of technique: clinical chemistry, immunoassays, point of care diagnostics, molecular diagnostics, haematology, coagulation and microbiology; type of product: instruments, reagents and data management systems; usability: disposable IVD devices and reusable IVD devices; applications: infectious diseases, diabetes, oncology, cardiology, autoimmune diseases, nephrology, drug testing, HIV/AIDS and others; and end-user: laboratory, academics, hospitals, point of care testing and others.
Some of the key players in the market are:
Key Deliverables in the Study